Sanofi’s Multaq approved to treat heart rhythm disorder, US
The U.S. Food and Drug Administration has approved Sanofi’s Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders or arrhythmia). Read more Sanofi’s Multaq approved to treat heart rhythm disorder, US Health News